Novo Nordisk A/S (NYSE:NVO)

53.84
Delayed Data
As of Mar 27
 +0.58 / +1.09%
Today’s Change
41.72
Today|||52-Week Range
54.38
+27.22%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line3.2B3.7B4.5B4.7B
 
 
 
 
 
Depreciation468.0M446.4M473.5M495.6M
 
 
 
 
 
Total Other Cash Flow254.3M-358.3M-291.1M808.8M
 
 
 
 
 
Funds From Operations3.9B3.8B4.7B6.0B
 
 
 
 
 
Funds From/For Other Operating Expenses-81.6M-47.5M47.3M380.7M
 
 
 
 
 
Net Cash Flow - Operating Activities4.0B3.9B4.6B5.6B
 
 
 
 
 
 
InvestingIncrease In Investments-37.0M-86.9M0.000.00
 
 
 
Decrease In Investments0.000.00149.8M401.8M
 
 
 
Capital Expenditures-577.5M-585.0M-577.5M-707.2M
 
 
 
 
 
Fixed Asset Disposal13.2M9.2M5.5M709.0K
 
 
 
 
 
Net Cash Flow Investing-650.1M-706.1M-494.6M-365.8M
 
 
 
 
 
 
FinancingShort Term Borrowings----0.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-95.3M-87.1M0.000.00
 
 
 
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed-2.0B-2.1B-2.5B-2.6B
 
 
 
 
 
Common Dividends-1.1B-1.3B-1.7B-2.1B
 
 
 
 
 
Cash Dividends Paid - Total-1.1B-1.3B-1.7B-2.1B
 
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-3.2B-3.5B-4.2B-4.7B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-3.0M-1.4M-12.5M12.1M
 
 
 
 
 
 
Net Change In Cash209.2M-346.3M-83.8M548.6M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account